These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Escitalopram in seasonal affective disorder: results of an open trial. Pjrek E, Winkler D, Stastny J, Praschak-Rieder N, Willeit M, Kasper S. Pharmacopsychiatry; 2007 Jan; 40(1):20-4. PubMed ID: 17327956 [Abstract] [Full Text] [Related]
4. Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study. Brennan BP, Fogarty KV, Roberts JL, Reynolds KA, Pope HG, Hudson JI. Hum Psychopharmacol; 2009 Jul; 24(5):423-8. PubMed ID: 19548294 [Abstract] [Full Text] [Related]
6. Assessment of depressive symptoms and functional outcomes in patients with major depressive disorder treated with duloxetine versus placebo: primary outcomes from two trials conducted under the same protocol. Oakes TM, Myers AL, Marangell LB, Ahl J, Prakash A, Thase ME, Kornstein SG. Hum Psychopharmacol; 2012 Jan; 27(1):47-56. PubMed ID: 22241678 [Abstract] [Full Text] [Related]
8. Open study of effects of alprazolam on seasonal affective disorder. Yamadera H, Okawa M, Takahashi K. Psychiatry Clin Neurosci; 2001 Feb; 55(1):27-30. PubMed ID: 11235853 [Abstract] [Full Text] [Related]
9. Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms. Russell JM, Weisberg R, Fava M, Hartford JT, Erickson JS, D'Souza DN. Depress Anxiety; 2008 Feb; 25(7):E1-11. PubMed ID: 17587217 [Abstract] [Full Text] [Related]
10. Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: a double-blind placebo-controlled trial. Davidson JR, Wittchen HU, Llorca PM, Erickson J, Detke M, Ball SG, Russell JM. Eur Neuropsychopharmacol; 2008 Sep; 18(9):673-81. PubMed ID: 18559291 [Abstract] [Full Text] [Related]
11. Examining quality of life in patients with generalized anxiety disorder: clinical relevance and response to duloxetine treatment. Pollack MH, Endicott J, Liebowitz M, Russell J, Detke M, Spann M, Ball S, Swindle R. J Psychiatr Res; 2008 Oct; 42(12):1042-9. PubMed ID: 18221755 [Abstract] [Full Text] [Related]
12. A controlled comparison of light box and head-mounted units in the treatment of seasonal depression. Levitt AJ, Wesson VA, Joffe RT, Maunder RG, King EF. J Clin Psychiatry; 1996 Mar; 57(3):105-10. PubMed ID: 8617693 [Abstract] [Full Text] [Related]
15. Treatment of seasonal affective disorder (SAD) with hypericum extract. Kasper S. Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():89-93. PubMed ID: 9342767 [Abstract] [Full Text] [Related]
16. Light therapy for seasonal affective disorder with blue narrow-band light-emitting diodes (LEDs). Glickman G, Byrne B, Pineda C, Hauck WW, Brainard GC. Biol Psychiatry; 2006 Mar 15; 59(6):502-7. PubMed ID: 16165105 [Abstract] [Full Text] [Related]
17. Therapeutic effects of escitalopram and reboxetine in seasonal affective disorder: a pooled analysis. Pjrek E, Konstantinidis A, Assem-Hilger E, Praschak-Rieder N, Willeit M, Kasper S, Winkler D. J Psychiatr Res; 2009 May 15; 43(8):792-7. PubMed ID: 19230909 [Abstract] [Full Text] [Related]
19. Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder. Arnold LM, Hudson JI, Wang F, Wohlreich MM, Prakash A, Kajdasz DK, Chappell AS. Clin J Pain; 2009 May 15; 25(6):461-8. PubMed ID: 19542792 [Abstract] [Full Text] [Related]